Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-7442

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-7442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\ra\desktop\1.jpg (5a5eca60 Figure 01)

This text appears to contain information related to blood pressure readings and medication dosages. It includes a comparison table showing different blood pressure levels, as well as the names and dosages of medications such as Valsartan-HCTZ, Valsartan, Hydrochlorothiazide, and Placebo. The table seems to represent the baseline SBP (systolic blood pressure) values in millimeters of mercury (mmHg).*

FDA Label Image

C:\users\ra\desktop\2.jpg (5a5eca60 Figure 02)

This description refers to a clinical trial or study evaluating the effects of different medications on blood pressure. The text shows different dosages of Valsartan-HCTZ, Valsartan, and Hydrochlorothiazide being tested along with a placebo. It also mentions baseline diastolic blood pressure (DBP) values and a threshold of DBP below 90 mmHg. The numbers include blood pressure measurements and medication dosages. No additional information is available.*

FDA Label Image

C:\users\ra\desktop\3.jpg (5a5eca60 Figure 03)

This text provides information on blood pressure levels for a study or clinical trial, mentioning values like 140, 145, and 150 mmHg, alongside medications such as Valsartan-HCTZ 320/25 mg. The document also includes baseline SBP values and lists Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo.*

FDA Label Image

C:\users\ra\desktop\4.jpg (5a5eca60 Figure 04)

This text appears to be displaying blood pressure values for different treatment groups. It includes Valsartan-HCTZ 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. It also mentions the baseline diastolic blood pressure (DBP) measurement. The information seems to be part of a clinical study or medical report.*

FDA Label Image

C:\users\ra\desktop\5.jpg (5a5eca60 Figure 05)

FDA Label Image

C:\users\ra\desktop\6.jpg (5a5eca60 Figure 06)

FDA Label Image

Label Image (Lbl500907442)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.